+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Catalyst Pharmaceuticals Inc (CPRX) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 54 Pages
  • June 2023
  • GlobalData
  • ID: 1314944
Catalyst Pharmaceuticals Inc (CPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops and commercializes prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as lambert-eaton myasthenic syndrome (LEMS) and focal onset seizures. The company also has various existing agreements to commercialize its products. Its product portfolio includes Firdapse, a proprietary form of amifampridine phosphate for the treatment of LEMS in children and adults. The company operates in the US and through its subsidiary in Ireland. Catalyst is headquartered in Coral Gables, Florida, the US.

Catalyst Pharmaceuticals Inc Key Recent Developments

  • Jun 01, 2023: Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
  • May 30, 2023: Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
  • Mar 15, 2023: Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
  • Mar 01, 2023: Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 15, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Catalyst Pharmaceuticals Inc - Key Facts
  • Catalyst Pharmaceuticals Inc - Key Employees
  • Catalyst Pharmaceuticals Inc - Key Employee Biographies
  • Catalyst Pharmaceuticals Inc - Major Products and Services
  • Catalyst Pharmaceuticals Inc - History
  • Catalyst Pharmaceuticals Inc - Company Statement
  • Catalyst Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Catalyst Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Catalyst Pharmaceuticals Inc - Corporate Strategy
  • Catalyst Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Catalyst Pharmaceuticals Inc - Strengths
  • Catalyst Pharmaceuticals Inc - Weaknesses
  • Catalyst Pharmaceuticals Inc - Opportunities
  • Catalyst Pharmaceuticals Inc - Threats
  • Catalyst Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Catalyst Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 01, 2023: Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
  • May 30, 2023: Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
  • Mar 15, 2023: Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
  • Mar 01, 2023: Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 15, 2023
  • Dec 20, 2022: Catalyst Pharmaceuticals to buy US rights for Eisai’s Fycompa
  • Nov 09, 2022: Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update
  • Aug 09, 2022: Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update
  • May 10, 2022: Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update
  • Mar 16, 2022: Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
  • Feb 03, 2022: Catalyst Pharmaceuticals reports preliminary fourth quarter and full year 2021 total revenues; provides 2022 total revenue guidance and corporate update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Catalyst Pharmaceuticals Inc, Key Facts
  • Catalyst Pharmaceuticals Inc, Key Employees
  • Catalyst Pharmaceuticals Inc, Key Employee Biographies
  • Catalyst Pharmaceuticals Inc, Major Products and Services
  • Catalyst Pharmaceuticals Inc, History
  • Catalyst Pharmaceuticals Inc, Subsidiaries
  • Catalyst Pharmaceuticals Inc, Key Competitors
  • Catalyst Pharmaceuticals Inc, Ratios based on current share price
  • Catalyst Pharmaceuticals Inc, Annual Ratios
  • Catalyst Pharmaceuticals Inc, Interim Ratios
  • Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Catalyst Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Catalyst Pharmaceuticals Inc, Performance Chart (2018 - 2022)
  • Catalyst Pharmaceuticals Inc, Ratio Charts
  • Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Marinus Pharmaceuticals Inc
  • Psyadon Pharmaceuticals Inc
  • GSK plc
  • ReceptoPharm Inc
  • Jacobus Pharmaceutical Co Inc
  • Marathon Pharmaceuticals LLC